Yes, infants in the US can receive a 6-in-1 vaccine, but it does NOT include pneumococcal conjugate (PCV13) or rotavirus vaccines.
A true six-in-one combination vaccine (DTaP-IPV-Hib-HepB, brand name Vaxelis) is FDA-licensed and available in the United States, covering diphtheria, tetanus, pertussis, polio, Haemophilus influenzae type b, and hepatitis B. 1
What the 6-in-1 Vaccine Actually Contains
The DTaP-IPV-Hib-HepB vaccine is licensed for infants aged 6 weeks through 4 years and is indicated for the primary vaccination series at ages 2,4, and 6 months 1. This single injection replaces what would otherwise require multiple separate injections at each visit.
Key Components:
- DTaP: Diphtheria, tetanus, and acellular pertussis
- IPV: Inactivated poliovirus vaccine
- Hib: Haemophilus influenzae type b conjugate
- HepB: Hepatitis B
What Is NOT Included
PCV13 (pneumococcal conjugate vaccine) and rotavirus vaccine are administered separately and are not part of any combination vaccine in the US 2. These vaccines must be given concomitantly (at the same visit) but as separate injections or oral administration (for rotavirus).
Important Clinical Considerations
Limitations of the 6-in-1 Vaccine:
- Cannot be used for the birth dose of hepatitis B - only for doses given at ≥6 weeks of age 1
- Not indicated for booster doses - only for the 3-dose primary series at 2,4, and 6 months 1
- Third dose minimum age is 24 weeks to ensure adequate hepatitis B immune response; if given earlier, an additional HepB dose is required at ≥24 weeks 1
- Should not be used for the Hib booster at 12-15 months - any licensed Hib conjugate vaccine can be used for the booster 1
Concomitant Administration:
The 6-in-1 vaccine has been studied with concomitant administration of:
These vaccines can and should be given at the same visit but require separate administration 2.
Special Population - American Indian/Alaska Native Infants:
DTaP-IPV-Hib-HepB does not have a preferential recommendation for AI/AN infants because data on antibody response after the first dose are not available. For these infants, PRP-OMP-containing Hib vaccines are preferred to provide early protection, as H. influenzae meningitis peaks earlier in this population (4-6 months vs. 6-7 months in other populations) 1.
Common Pitfall to Avoid
Do not confuse the 6-in-1 vaccine with a complete vaccination visit. Even when using DTaP-IPV-Hib-HepB, infants still require separate administration of PCV13 and rotavirus vaccine at the 2,4, and 6-month visits. The combination vaccine reduces the number of injections from potentially 4-5 down to 2 injections plus oral rotavirus, but does not eliminate all separate vaccines 2.